Back
Speaker illustration

Doctor Arnold Peter Raduly

University of Debrecen, Debrecen (Hungary)

Member of:

Heart Failure Association

Presentations

The novel myosin activator, danicamtiv alters both systolic and diastolic functions in vitro and in vivo

Event: Heart Failure 2024

Topic: Heart Failure

Session: ePosters in basic science 2

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources